Boon C. Goh
Expertise in
6
conditions

Boon C. Goh

2 Medical Dr, 
Singapore, SG 
Expertise in
6
conditions
2 Medical Dr, 
Singapore, SG 

Overview

Boon Goh practices practicing medicine in Singapore, Singapore.

Mr. Goh is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 143 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

2 Medical Dr, Singapore, 117593, Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers
Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers
Enrollment Status: Completed
Publish Date: January 12, 2026
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Cisplatin
Study Phase: Phase 2
Integrated Molecular Analysis of Cancer (IMAC)
Integrated Molecular Analysis of Cancer (IMAC)
Enrollment Status: Unknown
Publish Date: November 09, 2023
Intervention Type: Other
Phase II Open-label Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Systemic Therapy for Locally Advanced or Metastatic Nasopharyngeal Carcinoma (NPC)
Phase II Open-label Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Systemic Therapy for Locally Advanced or Metastatic Nasopharyngeal Carcinoma (NPC)
Enrollment Status: Completed
Publish Date: July 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

143 Total Publications

Publisher Correction: Translating genomic data into healthcare practice with the Singapore National Precision Medicine program.
Publisher Correction: Translating genomic data into healthcare practice with the Singapore National Precision Medicine program.
Journal: Nature genetics
Published: August 19, 2026

Frequently Asked Questions about Boon C. Goh

Is Boon C. Goh a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Boon C. Goh is classified as an Distinguished expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Boon C. Goh participate in research or clinical trials?

Yes. Boon C. Goh has published 143 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Boon C. Goh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Goh's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile